PRNewsWire - Health

Datasea Reports Second Fiscal Quarter 2025 Revenue of $20.5 Million, Up 81.4% Year-over-Year
IASO Bio Announces Acceptance of New Drug Application for Equecabtagene Autoleucel (FUCASO) by the Hong Kong Department of Health
Avertix's Guardian System Confirmed as Cost-Effective for High-Risk Acute Coronary Syndrome Patients
SS&C Announces Common Stock Dividend of $0.25 Per Share